Bel20 (BEL20.BXS)

Close: 5 350.06 (+47.69), Jan 15, 2026
Positive

Low risk

Automatic technical analysis. Medium term, Jan 15, 2026

Bel20 has broken the rising trend up in the medium long term. This signals an even stronger rate of growth, but the positive development may result in corrections down in the short term. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 5040 points. The short term momentum of the index is strongly positive, with RSI above 70. This indicates increasing optimism among investors and further price increase for Bel20. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 91)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.60%0.00+0.90%
5 days0.002.02%0.00+2.32%
22 days0.005.13%0.00+6.99%
66 days0.0010.16%0.00+8.71%

More analyses of Bel20

chart Bel20 (BEL20) Candlesticks 22 Days
Candlesticks
chart Bel20 (BEL20) Short term
Short term: Positive
chart Bel20 (BEL20) Medium term
Medium term: Positive
chart Bel20 (BEL20) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.